Quality and Efficacy Concerns with Generics in Treatment of Hepatitis C with Directly Acting Antivirals

Bader Faiyaz Zuberi


Treating hepatitis C has never been so convenient after
the advent of Directly Acting Antivirals (DAA).
Convenience is at both ends; for the doctors to prescribe
and for patients to comply due to all oral therapy with
few adverse effects. Many are already in market, these
include, Sofosbuvir, Declastavir & Velpastavir while
many others are in pipeline.

Full Text:


Copyright © 2004-2013 www.duhs.edu.pk, All rights Reserved